Stockreport

NeuroSense Regains Compliance with NASDAQ Minimum Bid Price Rule [Yahoo! Finance]

NeuroSense Therapeutics Ltd.  (NRSN) 
PDF neurodegenerative diseases, today announced that it has received notice from The Nasdaq Stock Market LLC ("Nasdaq") informing the Company that it has regained compliance [Read more]